Advancing global antibiotic research, development and access

2024/09/01 by Laura J. V. Piddock, Yewande Alimi, James Anderson +7 · 1 voice · 21 citations
Immunology and Microbiology · Biochemistry, Genetics and Molecular Biology · Environmental Science · #Antibiotic Use and Resistance #Antibiotic Resistance in Bacteria #Pharmaceutical and Antibiotic Environmental Impacts

paper · doi:10.1038/s41591-024-03218-w

Cited by

• Emerging Trends in Antimicrobial Resistance: A Global Review of Surveillance, Challenges, and Strategies
• Bacterial peptidoglycan as a living polymer. [europepmc]
• Artificial intelligence using a latent diffusion model enables the generation of diverse and potent antimicrobial peptides. [europepmc]
• An Australian perspective on clinical, economic and regulatory considerations in emerging nanoparticle therapies for infections. [europepmc]
• Not all disinfectants are created equal: the importance of mechanistic understanding to drive research forward. [europepmc]
• Current economic and regulatory challenges in developing antibiotics for Gram-negative bacteria. [europepmc]
• PET imaging of mycobacterial infection: transforming the pipeline for tuberculosis drug development. [europepmc]
• Isolation and characterization of bacteriophages with lytic activity against multidrug-resistant non-typhoidal Salmonella from Nairobi City county, Kenya. [europepmc]
• Open letter: challenging the removal of key bacteria from the updated 2024 WHO Bacterial Priority Pathogen List. [europepmc]
• Activity in an air-liquid interface lung infection model, feasibility of inhaled delivery, and stability of cell-free supernatants from Lacticaseibacillus rhamnosus against Pseudomonas aeruginosa pulmonary infections. [europepmc]
• Efflux-Mediated Resistance in Enterobacteriaceae : Recent Advances and Ongoing Challenges to Inhibit Bacterial Efflux Pumps. [europepmc]
• Development of a nitric oxide-releasing cephalexin-based hybrid compound for enhanced antimicrobial efficacy and biofilm disruption. [europepmc]
• "Dusting Off the Cobwebs": Rethinking How We Use New Antibiotics. [europepmc]
• The Perspectives of Combining Antibiotics with Saponins-Herbal Excipients. [europepmc]
• Children's drug research and development incentives and market pricing optimization based on medical imaging. [europepmc]
• From Tears to Toxins: Mapping Antibiotic Passage Through the Eye-Liver Axis. [europepmc]
• Halogenated Vitamin B 6 ‑Attached Co(III) Photosensitizers on Polypyridyl Scaffold for Light-Induced Antibacterial Activities. [europepmc]
• AntibioticDB: An Updated and Improved Open-Access Database for the Antibacterial Research and Development Community. [europepmc]
• Spirulina platensis as a novel natural antimicrobial against macrolide-resistant Mycoplasma gallisepticum in poultry. [europepmc]
• Restoration of daptomycin sensitivity with adjunctive cefazolin is associated with C-terminal MprF mutations in MRSA bacteremia isolates. [europepmc]
• The Role of Combination Antibiotic Therapy in Combatting Drug-Resistant Acinetobacter baumannii Infections: A Systematic Review of Randomised Control Trials. [europepmc]

Discussions

• In my upcoming series on the antibiotics crisis, I'll be addressing the issue that not only is it scientifically hard to come up with new compounds to replace the old waning ones, but even if you do, [bsky, 16 points, 1 comments]